SciSparc Subsidiary NeuroThera Labs Files Patent Application In Hong Kong For Novel Combination Treatment For Major Depressive Disorder, Developed In Collaboration With Clearmind Medicine

Benzinga Newsdesk www.benzinga.com Positive 90.4%

Neg 0% Neu 0% Pos 90.4%

Comments

No comments yet. Be the first!